DHL Supply Chain has launched a new €10 million dedicated facility for pharmaceutical logistics in Singapore.
The Pharma Hub is part of the DHL Group’s €500 million investment to bolster its Life Sciences and Healthcare (LSHC) infrastructure in the Asia Pacific region.
It also reflects DHL Group’s global focus on the healthcare sector as part of its Strategy 2030, which introduced the new “DHL Health Logistics” sector brand to drive cross-divisional growth.
The LSHC sector currently contributes €5 billion to DHL’s global revenue.
“At DHL Supply Chain, we are committed to supporting the rapidly growing LSHC sector in Asia Pacific where there is a growing demand for transformative healthcare solutions due to longer lifespans, personalised treatments and rising consumer expectations,” said DHL Supply Chain Asia Pacific CEO, Javier Bilbao.
“By 2030, the region’s medical market is projected to reach USD138 billion (~€127 billion), reflecting the critical need for resilient and efficient supply chains.
“As part of DHL Group’s Strategy 2030, we have invested ahead to strengthen our infrastructure and capabilities, ensuring we can meet the evolving and increasingly complex needs of our customers.”
Javier Bilbao added the investment in the new Pharma Hub goes beyond building warehouses or expanding networks.
“It is about building a foundation across all our business units that enables faster, more reliable delivery of life-saving medicines and healthcare products,” he said.
“In a region where healthcare demand is surging, we enable our customers to focus on innovation and patient care.
“At the same time, we handle the complexities of supply chain management across all logistics touch points – from storage, order fulfilment, and distribution to global shipping and last-mile delivery.
“This is how we deliver real value: by turning challenges into opportunities and ensuring that every link in the healthcare supply chain works seamlessly.”
The new 8,200-square metre Pharma Hub features specialised temperature-controlled zones including ambient (15°C to 25°C) and cold room (2°C to 8°C), ensuring precise storage conditions for sensitive healthcare products.
In addition, it is Good Manufacturing Practice (GMP) compliant with advanced cold chain infrastructure, including airtight loading docks and dedicated anterooms. These ensure uninterrupted temperature stability throughout the logistics process.
Strategically located near Tuas Bio-Medical Park, the Pharma Hub offers seamless connectivity to Changi Airport and Tuas Mega Port, enabling efficient regional and global distribution for pharmaceutical partners.
“Singapore is laser-focused on becoming a global leader in life sciences and medtech innovation,” said Managing Director, DHL Supply Chain Singapore, Eunis Hew.
Singapore’s 2025 budget includes a top-up of approximately €2 billion to attract investments in sectors, such as semiconductors and life sciences. The Government is also seeking to advance the National Research, Innovation and Enterprise (RIE) as part of its investment initiatives.
“With the new Pharma Hub in Jurong, we have over 36,000 square metres of warehouse space in Singapore dedicated to LSHC operations,” said Hew.
“Our current operations include being the regional distribution centres for multiple medical device multi-nationals, clinical trials support and other value-added services.”
DHL Supply Chain’s other investments in the LSHC industry across the Asia Pacific region include:
- €28 million in upgrades to automation, robotics, and expanded floor space at LSHC sites in New South Wales, Australia.
- A €26 million automated LSHC site in Auckland, New Zealand, featuring advanced technologies (automated pallet storage, tote robotic storage, and Goods-to-Person systems).
- Upcoming LSHC sites in South Korea to support critical deliveries to hospitals.
- An upcoming LSHC site in Bhiwandi, India.
DHL Supply Chain’s network of Good Distribution Practice (GDP)/ GMP-compliant facilities, specialised logistics solutions, including multi-temperature storage, transport, and its customised ‘white glove express delivery’ for extremely time-and-temperature-sensitive deliveries, position it to address structural shifts in the LSHC market.
With its investments in new additions and expanded capabilities, DHL Supply Chain will operate over 80 facilities with over 700,000 square meters of warehousing space in 13 countries across Asia Pacific, as well as employing more than 2,600 healthcare logistics experts and more than 40 full-time pharmacists in the region.
In other news, DHL has partnered with a chemical company.
